Yes. TheraPsil offers two distinct prescriber programs — one focused on psilocybin-assisted care and one on MDMA-assisted care.
Each course explores unique case scenarios, clinical applications, and regulatory frameworks. While some prescribers only take the training most relevant to their practice, many choose to complete both to support a wider range of patients.
